For US paramedics, what are the typical demographics, pathophysiology, signs and symptoms, assessment findings, EMS management (including ABCs, medication use, and transport decisions), and potential complications of eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Eclampsia: Comprehensive Overview for US National Paramedic Scope of Practice

General Condition and Pathophysiology

Eclampsia is defined as new-onset tonic-clonic, focal, or multifocal seizures or unexplained altered mental status in a pregnant or postpartum patient with preeclampsia or gestational hypertension, occurring after 20 weeks' gestation and up to 10 days postpartum (though rare cases occur beyond one week). 1, 2

The underlying pathophysiology involves a two-stage process: abnormal placental development leads to inadequate spiral artery remodeling in the uterus, causing placental ischemia (stage 1), which then triggers release of antiangiogenic factors (sFlt-1 and soluble endoglin) into maternal circulation, resulting in widespread endothelial damage affecting multiple organ systems (stage 2). 3 This endothelial dysfunction causes generalized vasoconstriction, reduced organ perfusion (heart, kidney, brain), hypertension, proteinuria, and ultimately seizures or altered mental status when cerebral involvement occurs.

Demographics and Pertinent History

High-risk demographics include:

  • Primigravida patients (first pregnancy) - 53.84% of eclampsia cases 4
  • Age extremes: particularly younger women (highest incidence ages 21-25 years) 4
  • Third trimester patients (57.4% of cases) 5
  • Patients from lower socioeconomic areas with inadequate prenatal care 5, 4
  • Multiparous women with previous preeclampsia
  • Patients with pre-existing vascular disease, obesity, chronic hypertension, or renal disease

Critical timing patterns:

  • Only 38% of eclamptic seizures occur antepartum
  • 18% occur during labor
  • 44% occur postpartum - making postpartum patients up to 10 days post-delivery at risk 2
  • Most postpartum cases occur ≥48 hours after delivery (73.84%) 4

Why these demographics align: Primigravida patients experience first-time placental implantation with higher risk of abnormal trophoblast invasion. Third trimester timing reflects progressive placental dysfunction and accumulated antiangiogenic factors. Lower socioeconomic status correlates with inadequate prenatal screening that would identify preeclampsia early. The high postpartum incidence occurs because endothelial damage persists after delivery while physiologic stress continues.

Major Signs and Symptoms

Cardinal presentation:

  • Tonic-clonic seizures (generalized convulsions)
  • Altered mental status or unexplained confusion
  • Severe headache (87.69% of cases) - most common prodromal symptom 4
  • Visual disturbances (blurred vision, scotomata, photophobia)
  • Right upper quadrant or epigastric pain (indicates hepatic involvement)
  • Nausea and vomiting

Critical caveat: Up to 38% of eclampsia cases occur without premonitory signs or symptoms of preeclampsia (no documented hypertension, proteinuria, or edema beforehand). 2 This makes eclampsia diagnostically challenging and emphasizes the need to consider it in ANY pregnant or recent postpartum patient with seizures.

Paramedic Assessment Findings

Early Assessment Findings:

  • Blood pressure: Hypertension present in most cases, but NOT required for diagnosis
    • Severe hypertension: SBP ≥160 mmHg or DBP ≥110 mmHg (14.9% of hypertensive obstetric patients) 5
    • However, normotensive eclampsia exists
  • Neurological prodrome:
    • Severe persistent headache unrelieved by analgesics
    • Visual changes (seeing spots, flashing lights)
    • Hyperreflexia with clonus
    • Altered mental status, confusion, agitation
  • Epigastric or RUQ pain (hepatic capsule distension)
  • Edema (hands, face, generalized) - though non-specific

Late/Critical Assessment Findings:

  • Active seizure activity - tonic-clonic, typically lasting 60-90 seconds
  • Post-ictal state with decreased level of consciousness
  • Status epilepticus (4.2% of cases) 6
  • Severe hypertension with end-organ damage signs
  • Pulmonary edema (43.07% of complications) - rales, respiratory distress, hypoxia 4
  • Signs of cerebrovascular accident (29.23% of complications) - focal neurological deficits 4
  • Decreased urine output (oliguria from renal involvement)
  • Signs of placental abruption (if antepartum) - vaginal bleeding, abdominal pain, fetal distress

Differentiation from signs/symptoms: Assessment findings are objective measurements (vital signs, physical exam findings, witnessed seizures) while signs/symptoms include subjective complaints (headache, visual changes) and observable manifestations (seizures, altered mental status). Assessment findings guide treatment intensity.

EMS Management and Treatment Protocol

Initial Scene Assessment and ABCs:

Airway:

  • Position patient left lateral decubitus if seizing (prevents aspiration, improves venous return)
  • Suction available - aspiration risk high
  • If post-ictal with decreased GCS, consider airway adjuncts (NPA/OPA)
  • Intubation indicated for: persistent altered mental status, inability to protect airway, status epilepticus, respiratory failure

Breathing:

  • High-flow oxygen 15L via non-rebreather to maintain SpO2 >95%
  • Monitor for pulmonary edema (common complication)
  • Capnography monitoring
  • Assisted ventilation with BVM if inadequate respiratory effort

Circulation:

  • IV access: Two large-bore IVs (18g or larger)
  • Fluid management: Conservative approach - avoid aggressive fluid boluses
    • If hypotensive (rare, suggests other pathology): 250-500mL crystalloid bolus cautiously
    • Maintenance fluids only: 80-100mL/hr to avoid pulmonary edema
    • Critical pitfall: Routine fluid expansion NOT recommended and can precipitate pulmonary edema 7

Seizure Management:

First-line treatment: Magnesium Sulfate 1, 7, 2

  • Loading dose: 4-6 grams IV over 15-20 minutes
    • Mix 4-6g in 100mL NS, infuse over 15-20 minutes
    • Can give 5g IM in each buttock (10g total) if IV access difficult
  • Maintenance infusion: 1-2 grams/hour continuous
  • Mechanism: Prevents and treats eclamptic seizures through cerebral vasodilation and neuroprotection
  • Monitoring: Assess for magnesium toxicity
    • Loss of deep tendon reflexes (first sign)
    • Respiratory depression (respiratory rate <12)
    • Decreased level of consciousness
    • Antidote: Calcium gluconate 1g (10mL of 10% solution) IV over 3 minutes

If seizures persist despite magnesium:

  • Benzodiazepines: Lorazepam 2-4mg IV or Midazolam 5-10mg IM/IV 8, 9
  • Avoid phenytoin - less effective than magnesium for eclamptic seizures

Hypertension Management:

Treatment threshold: SBP ≥160 mmHg or DBP ≥110 mmHg persistently

First-line antihypertensive options for paramedics:

  1. Labetalol (if available in scope):

    • 10-20mg IV bolus over 2 minutes
    • Repeat 20-40mg every 10 minutes (max 300mg)
    • Contraindications: asthma, heart failure, heart block
  2. Hydralazine (traditional first-line in Australia/UK):

    • 5mg IV bolus
    • Repeat 5-10mg every 20 minutes as needed
    • Onset 10-20 minutes
  3. Nifedipine (if oral medications in scope):

    • 10mg PO, may repeat in 30 minutes
    • Immediate release formulation

Goal: Moderate reduction in MAP, NOT normalization. Target SBP 140-150 mmHg, DBP 90-100 mmHg. Avoid precipitous drops that compromise placental perfusion. 9

Patient Assessment Protocol:

Primary survey:

  • Mental status (GCS)
  • Airway patency
  • Respiratory rate, effort, lung sounds
  • Blood pressure (both arms if possible)
  • Heart rate and rhythm
  • SpO2
  • Temperature
  • Blood glucose

Secondary survey:

  • Gestational age (if known)
  • Time since delivery (if postpartum)
  • Seizure characteristics (witnessed, duration, focal vs. generalized)
  • Headache severity and characteristics
  • Visual changes
  • Abdominal pain location
  • Vaginal bleeding
  • Fetal movement (if antepartum and mother can report)
  • Deep tendon reflexes
  • Edema assessment
  • Last prenatal visit and any known complications

Continuous reassessment every 5 minutes:

  • Vital signs
  • Neurological status
  • Respiratory status
  • Response to medications
  • Signs of recurrent seizure activity

Medication Management Summary:

Medications paramedics administer:

  1. Magnesium Sulfate

    • Indication: Eclamptic seizures, seizure prophylaxis in severe preeclampsia
    • Contraindication: Myasthenia gravis (relative)
    • Pharmacokinetics: IV onset 1-2 minutes, IM onset 60 minutes, duration 30 minutes after IV
    • Pharmacodynamics: CNS depressant, blocks neuromuscular transmission, cerebral vasodilator
    • Monitoring: Reflexes, respiratory rate, urine output
  2. Benzodiazepines (Lorazepam/Midazolam)

    • Indication: Seizures refractory to magnesium
    • Contraindication: Respiratory depression (relative in emergency)
    • Pharmacokinetics: Lorazepam onset 1-5 minutes IV, duration 6-8 hours; Midazolam onset 1-3 minutes, duration 2-6 hours
    • Pharmacodynamics: GABA-A receptor agonist, CNS depression
  3. Antihypertensives (Labetalol/Hydralazine)

    • Indication: SBP ≥160 or DBP ≥110 mmHg
    • Contraindications: Labetalol (asthma, heart block); Hydralazine (coronary artery disease)
    • Pharmacokinetics: Labetalol onset 2-5 minutes, peak 5-15 minutes; Hydralazine onset 10-20 minutes
    • Pharmacodynamics: Labetalol (alpha/beta blocker); Hydralazine (direct arterial vasodilator)
  4. Oxygen

    • Indication: Maintain SpO2 >95%
  5. Calcium Gluconate

    • Indication: Magnesium toxicity
    • Dose: 1g (10mL of 10% solution) IV over 3 minutes

Transport Decisions:

ALWAYS TRANSPORT - This is a load-and-go situation 1

Transport to:

  • Facility with obstetric services and ICU capabilities
  • Labor and delivery unit for pregnant patients
  • Emergency department with immediate obstetric consultation for postpartum patients
  • Definitive treatment requires delivery in pregnant patients 1

During transport:

  • Left lateral positioning (improves venous return, reduces aortocaval compression)
  • Continuous monitoring
  • Maintain magnesium infusion
  • Reassess vital signs every 5 minutes
  • Prepare for recurrent seizures
  • Notify receiving facility early - obstetric emergency requiring immediate specialist consultation
  • Consider ALS intercept if BLS unit
  • Do not delay transport for IV access or medication administration - can be performed en route

Reasons NOT to transport: NONE - eclampsia is always a transport situation requiring hospital-based definitive care

Scene time goal: <10 minutes for critical patients, minimize on-scene time

Chronic Condition Considerations

Eclampsia is NOT a chronic condition - it is an acute obstetric emergency. However, patients may have chronic conditions that predispose to preeclampsia/eclampsia:

Pre-existing medications patients may be taking:

  1. Chronic hypertension medications:

    • Methyldopa, labetalol, nifedipine (pregnancy-safe antihypertensives)
    • What they do: Control baseline blood pressure
    • Note: ACE inhibitors and ARBs are contraindicated in pregnancy
  2. Low-dose aspirin (81mg daily):

    • Indication: Preeclampsia prophylaxis in high-risk patients
    • Started before 16 weeks gestation
    • What it does: Reduces preeclampsia risk through antiplatelet effects and improved placental perfusion
  3. Prenatal vitamins with calcium:

    • Calcium supplementation may reduce preeclampsia risk

Post-eclampsia, patients may be discharged on:

  • Antihypertensives (labetalol, nifedipine) for persistent hypertension
  • These are NOT chronic medications for eclampsia itself, but for residual hypertension

Complications and Pathophysiology

Immediate Complications (if untreated):

  1. Maternal Death (case fatality rate 7.69% even with treatment, nearly 2% overall) 2, 4

    • Mechanism: Cerebral hemorrhage, status epilepticus, multi-organ failure
  2. Status Epilepticus (4.2% of cases) 6

    • Mechanism: Uncontrolled seizure activity from ongoing cerebral vasospasm and edema
    • Leads to: Hypoxic brain injury, aspiration, rhabdomyolysis
  3. Cerebrovascular Accident/Stroke (29.23% of complications) 4

    • Mechanism: Severe uncontrolled hypertension causes intracranial hemorrhage or posterior reversible encephalopathy syndrome (PRES)
    • Presents as: Focal neurological deficits, severe headache, altered mental status
  4. Pulmonary Edema (43.07% of complications - most common) 4

    • Mechanism: Increased capillary permeability from endothelial damage plus fluid overload
    • Presents as: Respiratory distress, hypoxia, rales
  5. Acute Kidney Injury (12.30% of complications) 4

    • Mechanism: Renal endothelial damage, glomerular endotheliosis, decreased renal perfusion
    • Presents as: Oliguria, elevated creatinine, electrolyte abnormalities
  6. HELLP Syndrome (15.38% of complications) 4

    • Hemolysis, Elevated Liver enzymes, Low Platelets
    • Mechanism: Microangiopathic hemolytic anemia, hepatic ischemia, platelet consumption
    • Presents as: RUQ pain, jaundice, bleeding
  7. Disseminated Intravascular Coagulation (DIC)

    • Mechanism: Widespread endothelial damage triggers coagulation cascade
    • Presents as: Bleeding from multiple sites, petechiae
  8. Placental Abruption (if antepartum)

    • Mechanism: Hypertension causes premature placental separation
    • Presents as: Vaginal bleeding, abdominal pain, fetal distress
  9. Multi-Organ Dysfunction Syndrome (MODS) (10.76% of complications) 4

    • Mechanism: Progressive failure of multiple organ systems from endothelial damage
    • High mortality
  10. Aspiration Pneumonia (6.15% of complications) 4

    • Mechanism: Aspiration during seizure or decreased consciousness
    • Presents as: Fever, hypoxia, infiltrates
  11. Cardiac Arrest

    • Mechanism: Severe hypertension, arrhythmias, pulmonary edema, or intracranial hemorrhage
    • Requires standard ACLS with modifications for pregnancy

Fetal/Neonatal Complications:

  • Stillbirth or neonatal death (approximately 1 in 14 cases) 2
  • Intrauterine growth restriction
  • Preterm delivery (often iatrogenic for maternal stabilization)
  • Placental insufficiency
  • Fetal hypoxia during maternal seizures

Long-term Maternal Complications:

  • Future cardiovascular disease risk increased 2.16-fold for ischemic heart disease 3
  • Future stroke risk increased 1.81-fold 3
  • Chronic hypertension risk increased 3.70-fold 3
  • Chronic kidney disease
  • Metabolic disorders
  • Recurrent preeclampsia in future pregnancies

Mechanism of long-term complications: Eclampsia represents underlying endothelial dysfunction and vascular disease that persists beyond pregnancy, serving as both a marker and contributor to future cardiovascular risk.

Critical Pitfalls to Avoid:

  1. Assuming normal blood pressure rules out eclampsia - normotensive eclampsia exists
  2. Aggressive fluid resuscitation - precipitates pulmonary edema
  3. Delaying magnesium for "confirmed" diagnosis - treat presumptively in pregnant/postpartum seizure patients
  4. Using phenytoin instead of magnesium - less effective for eclamptic seizures
  5. Forgetting postpartum patients - 44% of cases occur after delivery
  6. Excessive blood pressure reduction - compromises placental perfusion
  7. Prolonged scene time - this is load-and-go
  8. Dismissing complaints in postpartum patients - eclampsia can occur up to 10+ days post-delivery

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.